✦ LIBER ✦

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

✍ Scribed by Evaldo Nascimento; Demetrios F. Fernandes; Edva P. Vieira; Antonio Campos-Neto; Jill A. Ashman; Fabiana P. Alves; Rhea N. Coler; Lisa Y. Bogatzki; Stuart J. Kahn; Anna Marie Beckmann; Samuel O. Pine; Karen D. Cowgill; Steven G. Reed; Franco M. Piazza

Book ID: 116962943
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 335 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.07.063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical trial to evaluate the safety

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

✍ Alejandro Llanos-Cuentas; Wessmark Calderón; María Cruz; Jill A. Ashman; Fabiana 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 361 KB

A clinical trial to evaluate the safety

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine for use in the prevention of visceral leishmaniasis

✍ Jaya Chakravarty; Subodh Kumar; Sonali Trivedi; Vijay K. Rai; Anup Singh; Jill A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 349 KB

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1&#xa0;+&#xa0;MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis